Prostate Cancer Treatment May Double Risk of Alzheimer’s Disease

Prostate Cancer Treatment May Double Risk of Alzheimer’s Disease
A large-scale analysis of medical records revealed that men undergoing androgen deprivation therapy for prostate cancer treatment may be at almost twice the risk of eventually developing Alzheimer’s disease, and that the increased likelihood of the disease is proportional to ADT duration. The research paper, entitled “Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk,” was published in

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *